Genital Herpes Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Genital Herpes Market Expected To Expand Between 2025 And 2029?

The genital herpes market size has seen substantial growth over recent years. It is anticipated to expand from $2.19 billion in 2024 to $2.34 billion in 2025, progressing at a compound annual growth rate (CAGR) of 6.8%. The historical growth of this market can be attributed to factors like heightened awareness and diagnosis, continuous advancements in treatment options, enhanced access to healthcare services, dedicated public health campaigns, and prevailing socio-demographic elements.

The genital herpes market size is anticipated to undergo significant expansion in the coming years. This market is predicted to reach $2.99 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the forecast period include increasing awareness and educational efforts, progress in treatments and vaccines, a rise in incidence rates, the emergence of digital health technologies, broader healthcare accessibility, and an increase in STI awareness initiatives. Key trends anticipated within the forecast period encompass the wider adoption of telemedicine, breakthroughs in antiviral therapies, continued research and development for vaccines, an expansion of healthcare availability, more effective public awareness campaigns, and the incorporation of AI and data analytics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp

Which Industry Drivers Are Expected To Accelerate The Genital Herpes Market From 2025 To 2029?

The increasing emphasis on sexual health is projected to drive the expansion of the genital herpes market in the future. This growing attention to sexual health arises from a heightened understanding of its crucial contribution to overall well-being and life quality. Services for genital herpes within sexual health predominantly encompass diagnosis, therapy, guidance, and continuous management, aiding individuals in handling outbreaks, stopping transmission, and dealing with emotional and relationship issues tied to the condition. For example, in January 2024, the Local Government Association, a UK-based national membership body, reported a surge in demand for sexual health services, with close to 4.5 million consultations taking place in 2022, signifying a 33% increase. Furthermore, diagnostic testing showed considerable activity, with 2.2 million tests executed in 2022, a 13% rise from 2021. Consequently, the heightened focus on sexual health will stimulate the growth of the genital herpes market.

What Are The Major Segment Categories Driving The Genital Herpes Market Growth?

The genital herpesmarket covered in this report is segmented –

1) By Type: Diagnosis; Treatment

2) By Route Of Administration: Oral; Injectable; Topical

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channel

Subsegments:

1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests; Viral Culture Tests; Blood Antibody Tests (Serology); Antigen Detection Tests; Point-Of-Care Rapid Tests

2) By Treatment: Antiviral Medications; Acyclovir; Valacyclovir; Famciclovir; Topical Treatments; Acyclovir Cream; Docosanol Cream; Preventive Therapies; Suppressive Therapy; Prophylactic Vaccines (Under Development); Pain Management Medications; Analgesics; Topical Anesthetics

What Are The Major Trends Driving The Growth Of The Genital Herpes Market?

Leading companies engaged in the genital herpes market are increasingly adopting a strategic alliance approach to bolster their technological prowess and expand their market reach. A strategic partnership typically refers to a cooperative relationship among two or more organizations where they combine their resources, specialized knowledge, and efforts to achieve shared goals or objectives. For instance, in June 2022, Eurocine Vaccines AB, a biotechnology company based in Sweden specializing in herpes disease treatment therapies and related products, announced a research and collaboration agreement with Redbiotec AG, a Switzerland-based biotech firm. This agreement bestowed exclusive global rights for the development, production, and commercialization of vaccine candidates aimed at Herpes Simplex Virus Type 2 (HSV-2). The pact covers both mRNA- and protein-based technologies, along with relevant documentation and patents in the HSV-2 field. Eurocine Vaccines will manage and finance all activities related to development, manufacturing, and commercialization until a subsequent out-licensing deal with a third party is concluded.

Which Leading Players Are Enhancing Their Genital Herpes Market Presence Worldwide?

Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr. Reddy’s Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB, Vical Incorporated

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Genital Herpes Market?

North America was the largest region in the genital herpes market in 2024. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genital Herpes Market Report:

https://www.thebusinessresearchcompany.com/customise?id=17161&type=smp

Browse Through More Reports Similar to the Global Genital Herpes Market 2025, By The Business Research Company

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Cryogenic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Pump Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-pump-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795